These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24988744)

  • 1. [Indications and contraindications for platelet transfusions in patients with thrombocytopenia].
    Tomicić M; Vuk T; Hundrić-Haspl Z
    Lijec Vjesn; 2014; 136(3-4):90-3. PubMed ID: 24988744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New strategies for the optimal use of platelet transfusions.
    Blajchman MA; Slichter SJ; Heddle NM; Murphy MF
    Hematology Am Soc Hematol Educ Program; 2008; ():198-204. PubMed ID: 19074082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of platelets in transfusion medicine.
    Brubaker DB
    J Am Osteopath Assoc; 1989 Dec; 89(12):1553-9. PubMed ID: 2621122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia?
    Benjamin RJ; Anderson KC
    Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neonatal Platelet Transfusions and Future Areas of Research.
    Sola-Visner M; Bercovitz RS
    Transfus Med Rev; 2016 Oct; 30(4):183-8. PubMed ID: 27282660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of lower neonatal platelet transfusion thresholds.
    Hasan R; Saifee NH
    Transfusion; 2021 Jun; 61(6):1672-1675. PubMed ID: 33786866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A consistent approach to platelet transfusion in the NICU.
    Del Vecchio A; Motta M; Radicioni M; Christensen RD
    J Matern Fetal Neonatal Med; 2012 Oct; 25(Suppl 5):93-6. PubMed ID: 23025779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose of prophylactic platelet transfusions and prevention of hemorrhage.
    Slichter SJ; Kaufman RM; Assmann SF; McCullough J; Triulzi DJ; Strauss RG; Gernsheimer TB; Ness PM; Brecher ME; Josephson CD; Konkle BA; Woodson RD; Ortel TL; Hillyer CD; Skerrett DL; McCrae KR; Sloan SR; Uhl L; George JN; Aquino VM; Manno CS; McFarland JG; Hess JR; Leissinger C; Granger S
    N Engl J Med; 2010 Feb; 362(7):600-13. PubMed ID: 20164484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet transfusion therapy for medical and surgical patients.
    Hussein MA; Hoeltge GA
    Cleve Clin J Med; 1996; 63(4):245-50. PubMed ID: 8764695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet transfusion for patients with cancer.
    Fletcher CH; DomBourian MG; Millward PA
    Cancer Control; 2015 Jan; 22(1):47-51. PubMed ID: 25504278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utilization of platelet transfusions in the intensive care unit: indications, transfusion triggers, and platelet count responses.
    Arnold DM; Crowther MA; Cook RJ; Sigouin C; Heddle NM; Molnar L; Cook DJ
    Transfusion; 2006 Aug; 46(8):1286-91. PubMed ID: 16934061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic use of platelets in critically ill patients with thrombocytopaenia: A retrospective two-centre observational study.
    O'Bryan LJ; Bedford J; Redfern OC; Hatch RA; Young JD; Watkinson PJ
    J Crit Care; 2020 Jun; 57():157-167. PubMed ID: 32163751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current practice and future directions for optimization of platelet transfusions in patients with severe therapy-induced cytopenia.
    Apelseth TO; Hervig T; Bruserud O
    Blood Rev; 2011 May; 25(3):113-22. PubMed ID: 21316823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Background, rationale, and design of a clinical trial to assess the effects of platelet dose on bleeding risk in thrombocytopenic patients.
    Slichter SJ
    J Clin Apher; 2006 Apr; 21(1):78-84. PubMed ID: 16619231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet transfusions.
    Stroncek DF; Rebulla P
    Lancet; 2007 Aug; 370(9585):427-38. PubMed ID: 17679020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study.
    Vadhan-Raj S; Kavanagh JJ; Freedman RS; Folloder J; Currie LM; Bueso-Ramos C; Verschraegen CF; Narvios AB; Connor J; Hoots WK; Broemeling LD; Lichtiger B
    Lancet; 2002 Jun; 359(9324):2145-52. PubMed ID: 12090979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interventions to reduce platelet prophylactic transfusions in patients with hypoproliferative thrombocytopenia: providing patients with the full benefit.
    Vamvakas EC; Hitzler WE
    Clin Lab; 2013; 59(5-6):459-64. PubMed ID: 23865342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and cost effectiveness of a 10 x 10(9)/L trigger for prophylactic platelet transfusions compared with the traditional 20 x 10(9)/L trigger: a prospective comparative trial in 105 patients with acute myeloid leukemia.
    Wandt H; Frank M; Ehninger G; Schneider C; Brack N; Daoud A; Fackler-Schwalbe I; Fischer J; Gäckle R; Geer T; Harms P; Löffler B; Ohl S; Otremba B; Raab M; Schönrock-Nabulsi P; Strobel G; Winter R; Link H
    Blood; 1998 May; 91(10):3601-6. PubMed ID: 9572994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of platelet and plasma transfusion on outcome in traumatic brain injury patients with moderate bleeding diatheses.
    Anglin CO; Spence JS; Warner MA; Paliotta C; Harper C; Moore C; Sarode R; Madden C; Diaz-Arrastia R
    J Neurosurg; 2013 Mar; 118(3):676-86. PubMed ID: 23259827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. POLYMORPHISM OF COLLECTION, TRANSFUSION AND EFFECTIVENESS OF DONOR PLATELETS CONCENTRATES.
    Gubanova MN; Ayupova RF; Zhiburt EB
    Anesteziol Reanimatol; 2017 Jan; 62(1):77-79. PubMed ID: 29932588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.